Documents

Ideas Discussions Technicals Forecast Seasonals Options

TELA Bio, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from TELA Bio, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Canaccord Genuity’s 45th Annual Growth Conference

Aug 13, 2025

Transcript

Q2 2025

Aug 11, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

Investor Presentation

Aug 10, 2025

Slides

Q1 2025

May 08, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

2024

Q4 2024

Mar 20, 2025

Transcript

Annual report10-K

Earnings release8-K

Q3 2024

Nov 07, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 12, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 09, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 21, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 09, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 09, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 11, 2023

Quarterly report10-Q

Earnings release8-K

JPMorgan Healthcare Conference

Jan 12, 2023

Slides

2022

Q4 2022

Mar 21, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 09, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 10, 2022

Quarterly report10-Q

Earnings release8-K

2021

Q4 2021

Mar 23, 2022

Annual report10-K

2020

Q4 2020

Mar 25, 2021

Annual report10-K

2019

Q4 2019

Mar 30, 2020

Annual report10-K